Search results
-addressing-a-new-global-health-challenge/ |journal=NIHR Evidence |doi=10.3310/nihrevidence_50331 |s2cid=249942230}}</ref> The most commonly reported clinical...368 KB (32,620 words) - 06:47, 9 August 2024
Themed Reviews |publisher=[[National Institute for Health Research]] |doi=10.3310/themedreview_41169 |doi-access=free |title-link=doi}}</ref><ref...288 KB (33,179 words) - 15:02, 20 August 2024
|volume=14 |issue=32 |pages=1–206 |date=June 2010 |pmid=20594533 |doi=10.3310/hta14320|doi-access=free }}</ref> Daily use of [[tamoxifen]] or [[raloxifene]]...185 KB (20,011 words) - 23:20, 15 August 2024
(journal)|Health Technology Assessment]]|volume=17|issue=43|pages=1–253|doi=10.3310/hta17430|pmc=4781046|pmid=24074752}}</ref> Nevertheless, many [[clinical...130 KB (13,860 words) - 13:46, 21 August 2024
Technology Assessment |volume=13 |issue=41 |pages=1–190, 215–357, iii–iv |doi=10.3310/hta13410 |pmid=19726018 |doi-access=free |hdl=10536/DRO/DU:30064294|hdl-access=free...128 KB (12,971 words) - 13:54, 21 August 2024
|access-date=8 June 2022 |website=NIHR Evidence |doi=10.3310/nihrevidence_50885 |s2cid=249937345 |language=en-GB}}</ref><ref>{{cite journal...120 KB (12,708 words) - 18:58, 21 April 2024
issue = 28 | pages = 1–272 | date = October 2022 | pmid = 36223438 | doi = 10.3310/RTLH7522 | hdl-access = free | s2cid = 252707680 | doi-access = free | hdl...185 KB (20,504 words) - 06:38, 17 August 2024
|language=en |publisher=National Institute for Health and Care Research |doi=10.3310/nihrevidence_53342|s2cid=253347210 }}</ref><ref name="Zhou-2020">{{cite...189 KB (21,105 words) - 13:35, 20 August 2024
iii–iv, 1–191 | date = July 2012 | pmid = 22814301 | pmc = 4781281 | doi = 10.3310/hta16310 | publisher = [[National Institute for Health and Care Research]]...143 KB (14,266 words) - 18:26, 12 August 2024
|access-date=2024-05-31 |website=NIHR Evidence |doi=10.3310/alert_48575 |language=en-GB}}</ref><ref>{{Cite journal |last1=Vinogradova...131 KB (14,807 words) - 09:16, 20 August 2024
issue = 12 | pages = i–iv, 1–62 | year = 1997 | pmid = 9483155 | doi = 10.3310/hta1120 | doi-access = free }} * {{cite journal | vauthors = Grier DJ, Watson...101 KB (11,806 words) - 11:00, 8 August 2024
help-people-with-psychosis-and-agoraphobia/ |journal=NIHR Evidence|doi=10.3310/nihrevidence_59108 |s2cid=260053713 }}</ref> During the COVID-19 pandemic...112 KB (12,150 words) - 22:43, 21 August 2024
Evidence |publisher=National Institute for Health and Care Research |doi=10.3310/nihrevidence_59456 |s2cid=260965684}}</ref> In many areas of the world,...166 KB (18,146 words) - 18:40, 19 August 2024
Technology Assessment]]|volume=13|issue=6|pages=iii–iv, ix–xii, 1–315|doi=10.3310/hta13050|pmid=19195429|doi-access=free|hdl=10871/11534|hdl-access=free}}</ref><ref...166 KB (15,881 words) - 07:54, 15 August 2024
(journal)|Health Technology Assessment]]|volume=17|issue=43|pages=1–253|doi=10.3310/hta17430|pmc=4781046|pmid=24074752}}</ref> <!-- Epidemiology --> Cardiovascular...137 KB (14,460 words) - 07:12, 12 August 2024- |access-date=2024-05-31 |website=NIHR Evidence |doi=10.3310/alert_48882 |language=en-GB}}</ref><ref>{{Cite journal |last1=Cameron |first1=Sharon...155 KB (15,794 words) - 21:43, 10 August 2024
-dementia-and-care-that-preserves-dignity/ |journal=NIHR Evidence |doi=10.3310/nihrevidence_51255|s2cid=251785991 }}</ref><ref>{{cite journal | vauthors...202 KB (22,761 words) - 21:36, 17 August 2024
issue = 8 | pages = 1–206 | date = May 2019 | pmid = 31046212 | doi = 10.3310/phr07080 | doi-access = free | hdl = 1893/29477 | hdl-access = free }}</ref><ref...175 KB (18,752 words) - 05:04, 2 August 2024- sd-is-as-effective-as-face-to-face-therapy/ |journal=NIHR Evidence|doi=10.3310/nihrevidence_56507 |s2cid=257844874 |url-access=subscription }}</ref><ref>{{cite...204 KB (22,305 words) - 03:48, 20 August 2024
- uk/alert/vaccines-reduce-the-risk-of-long-covid/ |journal=NIHR Evidence|date=2024 |doi=10.3310/nihrevidence_63203 }}</ref> === Duration of immunity === As of 2021, available...199 KB (22,726 words) - 08:47, 6 August 2024
